Cipla Limited Issues Notice for IEPFA Second 100-Day Campaign 'Saksham Niveshak'
Cipla Limited has published newspaper advertisements on April 15, 2026, in Business Standard and Sakal regarding the IEPFA Second 100-Day Campaign 'Saksham Niveshak' to facilitate dividend claims and KYC updates. The notice, issued under SEBI Regulation 30, has been communicated to BSE, NSE, and Luxembourg Stock Exchange, with detailed information available on the company website and through appointed agencies Link Intime India Private Limited and Kfin Technologies Limited.

*this image is generated using AI for illustrative purposes only.
Cipla Limited has issued an important notice to its shareholders regarding the IEPFA Second 100-Day Campaign - 'Saksham Niveshak', aimed at facilitating dividend claims and KYC updates. The pharmaceutical company published newspaper advertisements on April 15, 2026, in leading publications to ensure maximum reach to its shareholder base.
Regulatory Compliance and Publication Details
The notice was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company published advertisements in Business Standard (English) and Sakal (Marathi) newspapers on April 16, 2026, ensuring compliance with regulatory requirements for shareholder communication.
| Publication Details: | Information |
|---|---|
| Advertisement Date: | April 15, 2026 |
| Publication Date: | April 16, 2026 |
| English Newspaper: | Business Standard |
| Marathi Newspaper: | Sakal |
| Website Hosting: | www.cipla.com |
Campaign Objectives and Shareholder Benefits
The 'Saksham Niveshak' campaign represents the second phase of the 100-day initiative designed to help shareholders claim their unclaimed dividends and update their KYC (Know Your Customer) information. This initiative is particularly important for shareholders who may have unclaimed dividends or require documentation updates to maintain their investment records.
Appointed Service Agencies
Cipla has appointed two specialized agencies to assist shareholders with their claims and documentation processes:
| Service Provider: | Contact Details |
|---|---|
| Link Intime India Private Limited: | C-101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai - 400 083 |
| Kfin Technologies Limited: | Selenium Tower B, Plot No. 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampalli, Hyderabad - 500 032 |
Documentation and Process Information
The company has made detailed information available on its website under the 'Corporate Governance' section, specifically in the 'Investor Service Forms' subsection. Shareholders can access the applicable ISR (Investor Service Request) forms and other necessary documentation through the company's official website.
Stock Exchange Communication
The notice was formally communicated to major stock exchanges including BSE Limited (Scrip Code: 500087), National Stock Exchange of India Limited (Scrip Code: CIPLA), and Societe de la Bourse de Luxembourg. This ensures comprehensive regulatory compliance across all trading platforms where Cipla shares are listed.
The document was signed by Rajendra Chopra, Company Secretary, and dated April 16, 2026, from Mumbai, demonstrating the company's commitment to transparent shareholder communication and regulatory compliance.
Historical Stock Returns for Cipla
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.84% | +1.34% | -4.55% | -20.94% | -17.08% | +32.27% |
What is the total value of unclaimed dividends that Cipla expects to recover through this second phase campaign?
How might improved KYC compliance and reduced unclaimed dividends impact Cipla's cash flow and balance sheet in upcoming quarters?
Will other pharmaceutical companies follow Cipla's proactive approach to shareholder engagement, potentially setting a new industry standard?


































